BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27401842)

  • 1. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
    Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
    Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of high-grade cervical intraepithelial neoplasia by p16
    Vink FJ; Dick S; Heideman DAM; De Strooper LMA; Steenbergen RDM; Lissenberg-Witte BI; ; Floore A; Bonde JH; Oštrbenk Valenčak A; Poljak M; Petry KU; Hillemanns P; van Trommel NE; Berkhof J; Bleeker MCG; Meijer CJLM
    Int J Cancer; 2021 Aug; 149(3):707-716. PubMed ID: 33729551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
    El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
    Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
    Wentzensen N; Sherman ME; Schiffman M; Wang SS
    Gynecol Oncol; 2009 Feb; 112(2):293-9. PubMed ID: 19054549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
    Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
    Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].
    Xu J; Wang HL; Lu GC; Wang ZJ; Lin X; Zhou HW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):394-7. PubMed ID: 17697601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
    Lin Z; Gao M; Zhang X; Kim YS; Lee ES; Kim HK; Kim I
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction between polycyclic aromatic hydrocarbons and
    Wang L; Liu XZ; Ren ZY; Ding L; Nan J; Liu CL; Song ZC; Feng MJ; Yang Q; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1113-1117. PubMed ID: 28847065
    [No Abstract]   [Full Text] [Related]  

  • 12. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
    Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
    Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
    Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
    Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
    Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
    Bukowski A; Hoyo C; Vielot NA; Graff M; Kosorok MR; Brewster WR; Maguire RL; Murphy SK; Nedjai B; Ladoukakis E; North KE; Smith JS
    BMC Cancer; 2023 Nov; 23(1):1072. PubMed ID: 37932662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Sun C; Reimers LL; Burk RD
    Gynecol Oncol; 2011 Apr; 121(1):59-63. PubMed ID: 21306759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
    Bulten J; van der Avoort IA; Melchers WJ; Massuger LF; Grefte JM; Hanselaar AG; de Wilde PC
    Gynecol Oncol; 2006 Jun; 101(3):487-94. PubMed ID: 16406113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.
    DE Lima TM; DE Azevedo Focchi GR; DE Almeida BC; Belfort-Mattos PN; Heinke T; DE Góis Speck NM
    Anticancer Res; 2018 Dec; 38(12):6673-6681. PubMed ID: 30504376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.
    Yin A; Zhang Q; Kong X; Jia L; Yang Z; Meng L; Li L; Wang X; Qiao Y; Lu N; Yang Q; Shen K; Kong B
    Oncotarget; 2015 Dec; 6(42):44373-87. PubMed ID: 26517242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.